Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns

16Citations
Citations of this article
85Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Identification of actionable genomic vulnerabilities is key to precision oncology. Utilizing a large-scale drug screening in patient-derived xenografts, we uncover driver gene alteration connections, derive driver co-occurrence (DCO) networks, and relate these to drug sensitivity. Our collection of 53 drug-response predictors attains an average balanced accuracy of 58% in a cross-validation setting, rising to 66% for a subset of high-confidence predictions. We experimentally validated 12 out of 14 predictions in mice and adapted our strategy to obtain drug-response models from patients' progression-free survival data. Our strategy reveals links between oncogenic alterations, increasing the clinical impact of genomic profiling.

References Powered by Scopus

Cytoscape: A software Environment for integrated models of biomolecular interaction networks

35083Citations
N/AReaders
Get full text

New guidelines to evaluate the response to treatment in solid tumors

14954Citations
N/AReaders
Get full text

The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data

12393Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches

368Citations
N/AReaders
Get full text

Anticancer drug resistance: An update and perspective

232Citations
N/AReaders
Get full text

Basket Trials: Review of Current Practice and Innovations for Future Trials

20Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mateo, L., Duran-Frigola, M., Gris-Oliver, A., Palafox, M., Scaltriti, M., Razavi, P., … Aloy, P. (2020). Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns. Genome Medicine, 12(1). https://doi.org/10.1186/s13073-020-00774-x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

50%

Researcher 16

42%

Professor / Associate Prof. 2

5%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 18

46%

Agricultural and Biological Sciences 9

23%

Medicine and Dentistry 9

23%

Pharmacology, Toxicology and Pharmaceut... 3

8%

Article Metrics

Tooltip
Mentions
News Mentions: 3
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free